Adverum: Speculative Gene Therapy Play With In-House Capabilities Targeting The Validated And Attractive Ocular SpaceSeeking Alpha • 06/24/19
Adverum Biotechnologies, Inc. (ADVM) Shares March Higher, Can It Continue?Zacks Investment Research • 05/24/19
Adverum Announces Clinical Hold, But It Should Not Hinder Its Gene Therapy PathSeeking Alpha • 04/17/19